share_log

Morgan Stanley Downgrades Vigil Neuroscience to Underweight, Lowers Price Target to $4

Benzinga ·  Dec 19, 2023 09:31

Morgan Stanley analyst Jeffrey Hung downgrades Vigil Neuroscience (NASDAQ:VIGL) from Equal-Weight to Underweight and lowers the price target from $13 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment